Free Trial

United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts

United Therapeutics logo
$374.02
+0.05 (+0.01%)
(As of 11/1/2024 ET)

United Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 19Estimated
Actual EPS
(Oct. 30)
$6.39 Beat By $0.23
Consensus EPS
(Oct. 30)
$6.16

United Therapeutics posted Q3 2024 earnings on October 30, 2024, reporting an EPS of $6.39, which topped the consensus estimate of $6.16 by $0.23. Quarterly revenue rose 22.9% year-over-year to $748.90 million, above analysts' expectations of $722.62 million. With a trailing EPS of $22.77 and a P/E Ratio of 16.43, United Therapeutics' earnings are expected to grow 11.07% next year, from $24.85 to $27.60 per share.

UTHR Upcoming Earnings

United Therapeutics' next earnings date is estimated for Wednesday, February 19, 2025, based off prior year's reporting schedules.

Get United Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

UTHR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UTHR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

United Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242$5.10$5.93$5.52
Q2 20243$5.55$6.50$5.92
Q3 20243$5.69$7.41$6.33
Q4 20242$5.40$7.83$6.62
FY 202410$21.74$27.67$24.38
Q1 20251$6.59$6.59$6.59
Q2 20251$6.36$6.36$6.36
Q3 20251$6.26$6.26$6.26
Q4 20251$5.65$5.65$5.65
FY 20254$24.86$24.86$24.86
Q1 20261$6.42$6.42$6.42
Q2 20261$6.62$6.62$6.62

United Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/19/2025
(Estimated)
------- 
10/30/2024Q3 2024$6.16$6.39+$0.23$6.39$722.62M$748.90M          
7/31/2024Q2 2024$6.33$5.85 -$0.48$5.85$691.87M$714.90M        
5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31M$677.70M          
2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01M$614.70M          
11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82M$609.40M          
8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18M$596.50M        
5/3/2023Q1 2023$4.26$4.86+$0.60$4.86$514.37M$506.90M      
2/22/2023Q4 2022$4.12$2.67 -$1.45$2.67$519.20M$491.50M        
11/2/2022Q3 2022$3.57$4.91+$1.34$4.91$492.92M$516.00M  

United Therapeutics Earnings - Frequently Asked Questions

United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates. Learn more on UTHR's earnings history.

In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $6.39 earnings per share (EPS) to beat the analysts' consensus estimate of $6.16 by $0.23. Learn more on analysts' earnings estimate vs. UTHR's actual earnings.

The conference call for United Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for United Therapeutics's latest earnings report can be read online.
Read Transcript

United Therapeutics's earnings report can be found in their filing with the SEC.
View SEC filing

United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.33 billion.

United Therapeutics (NASDAQ:UTHR) has a recorded net income of $984.80 million. UTHR has generated $22.77 earnings per share over the last four quarters.

United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 16.43 and a forward price-to-earnings ratio of 15.05. The price/earnings-to-growth ratio is 1.35.

United Therapeutics's earnings are expected to grow from $24.85 per share to $27.60 per share in the next year, which is a 11.07% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:UTHR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners